Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 325851, 11 pages
http://dx.doi.org/10.1155/2015/325851
Research Article

Metformin Treatment in Type 2 Diabetes in Pregnancy: An Active Controlled, Parallel-Group, Randomized, Open Label Study in Patients with Type 2 Diabetes in Pregnancy

1Department of Obstetrics and Gynecology, Dow University of Health Sciences, Karachi 74400, Pakistan
2Department of Pharmacology, Medical and Dental College, Bahria University, Karachi 75500, Pakistan
3School of Public Health, Dow University of Health Sciences, Karachi 75300, Pakistan
4Department of Community Health Sciences, United Medical and Dental College, Karachi 74900, Pakistan
5Department of Obstetrics and Gynecology, Hamdard University Hospital, Karachi 74400, Pakistan

Received 14 December 2014; Revised 12 February 2015; Accepted 20 February 2015

Academic Editor: Vipin Gupta

Copyright © 2015 Jahan Ara Ainuddin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Patients in metformin group had good treatment compliance when compared to insulin group P<0.01. Only six patients had gastro intestinal side effects resulting in dose limitation in metformin group. 92.4% patients opted for metformin treatment in next pregnancy while all patients in metformin group considered metformin treatment as easy and cheap. Doing finger pricks for blood glucose monitoring was considered as the most difficult part of treatment in both groups.

  1. Supplementary Material